Form 4 for BIO BIO-RAD LABORATORIES, INC.
Accepted 2023-04-11 00:00:00 ET · period of report 2023-04-08 · accession 0001062993-23-009008 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-04-11 | 2023-04-08 | BIO | Daskal Ilan | EVP, CFO | M - OptEx | $0.00 | +700 | 1,736 | +68% | $0 |
| D | 2023-04-11 | 2023-04-08 | BIO | Daskal Ilan | EVP, CFO | F - Tax | $466.24 | -243 | 1,493 | -14% | -$113.3K |
| D | 2023-04-11 | 2023-04-08 | BIO | Daskal Ilan | EVP, CFO | M - OptEx | $0.00 | -700 | 700 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Bio-Rad A Common Stock | 2023-04-08 | M | A | 700 | $0.00 | 1,736.27 | D | — | — | (F1) Shares of Class A common stock acquired on the vesting of restricted stock units. (F2) Includes 44.9320 and 38.3360 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 12/30/2022 and 3/31/2023, respectively. |
| 2 | Common | Bio-Rad A Common Stock | 2023-04-08 | F | D | 243 | $466.24 | 1,493.27 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2023-04-08 | M | D | 700 | $0.00 | 700 | D | $0.00 · — to — | 700 Bio-Rad A Common Stock | (F3) Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. (F4) On April 8, 2019, the reporting person was granted 3,500 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. |